A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
Ekso Bionics has recently delivered the ready-to-wear, battery-powered Ekso exoskeleton to its first customer, the Craig Hospital in Denver, an institution dedicated to spinal cord injury and traumatic brain injury rehabilitation. MedGadget